GENEVA—A new study led by the Institut Rosell-Lallemand and presented at Vitafoods International found a three-month daily supplementation with ProbioKid® during the winter reduced the risks of common infections in children.
The study was conducted during the winter of 2006 to 2007 and involved 135 healthy, school-age children who had suffered from at least three episodes of ear-nose-throat (ENT), bronchopulmonary or gastric disorder during the course of the previous winter. Fifty percent of the children in the synbiotic group did not develop any ENT, bronchopulmonary or gastric disorder during the winter versus 32.9 percent in the placebo group (P<0.05). This represents a 25-percent reduction of the relative risk of infectious disease in the ProbioKid group compared to the placebo group (P<0.05).
In addition, only 25.8 percent of children in the synbiotic group missed at least one day of school versus 42.5 percent in the placebo group (P<0.05).